(Q80794415)

English

Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings

scientific article published on 01 October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

based on heuristic

inferred from title

Kisaburo Hanazawa

9

object named as

Kisaburo Hanazawa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shigetaka Asano

37

object named as

Shigetaka Asano

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

19

object named as

Arinobu Tojo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Satoshi Takahashi

16

object named as

Satoshi Takahashi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Kenzaburo Tani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Miyuki Azuma

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yukoh Nakazaki

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Naoki Oyaizu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hidenori Hase

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Junko Ohata

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Keisuke Takahashi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Maki OiwaMonna

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yoshiaki Wakumoto

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kouji Kawai

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Masayuki Noguchi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yasushi Soda

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Reiko Kunisaki

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kiyoshi Watari

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Utako Machida

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Noriharu Satoh

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Taira Maekawa

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Masazumi Eriguchi

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shinji Tomikawa

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hideaki Tahara

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yusuke Inoue

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hiroki Yoshikawa

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yoshitsugu Yamada

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Aikichi Iwamoto

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hirofumi Hamada

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Naohide Yamashita

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Koh Okumura

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Tadao Kakizoe

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hideyuki Akaza

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Makoto Fujime

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shirley Clift

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Dale Ando

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Richard Mulligan

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

799-816

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

The prevalence of renal cell carcinoma: a nation-wide survey in Japan in 1997

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

GM-CSF-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Advanced renal cell carcinoma treated with granulocyte-macrophage colony-stimulating factor gene therapy: a clinical course of the first Japanese experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Immune recognition of a human renal cancer antigen through post-translational protein splicing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Effectiveness of very low doses of immunotherapy in advanced renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

TCR-Vbeta repertoire analysis with RT-PCR was useful for the early detection of pulmonary relapsed T-cell lymphoma after autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.07.001

7 January 2021

Identifiers

10.1016/J.YMTHE.2004.07.001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15451464%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80794415&oldid=1873410758"